|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
 Back to Reuters Health News Archives
Reuters Health News: 02-25-2005
HO CHI MINH CITY (Reuters) - Asian countries battling a bird flu virus that threatens to create a human pandemic that could kill millions need urgent help from the wealthy West if they are to succeed, a 28-nation conference said on Friday.
LONDON (Reuters) - There is no evidence that vaccinating children under 2 years old against influenza reduces deaths or complications from the illness, researchers said on Friday.
GENEVA (Reuters) - A two-year-old girl has contracted polio in Ethiopia in another sign that the epidemic is spreading across Africa, the World Health Organization (WHO) said on Friday.
NEW YORK (Reuters Health) - Despite the fact that a blood infection called bacterial sepsis is one of the most frequent causes of death in people who have received platelet transfusions, most infectious-disease specialists are not aware of recent standards requiring bacterial testing for contamination of platelets, according to a new report.
LONDON (Agence de Presse Medicale) - Men are more likely than women to take up invitations for bowel screening, according to a large Cancer Research UK study published in the current issue of the Journal of Medical Screening.
WASHINGTON (Reuters) - A consumer group sued the federal government on Thursday, saying that salt is killing tens of thousands of Americans and that regulators have done too little to control salt in food.
WASHINGTON (Reuters) - AIDS experts who created an uproar when they publicized the case of a man infected with an apparently uniquely dangerous mutant of HIV said on Thursday it was important to warn health officials.
LONDON (Reuters) - Having a planned caesarian section does not reduce a woman's risk of suffering from postnatal depression, doctors said Friday.
LONDON (Reuters) - Unsafe drinking water and poor sanitation kill 4,000 children every day, global health experts said on Friday.
ROCKVILLE, Md. (Reuters) - AstraZeneca Plc should be allowed to market its hypertension drug Atacand to heart failure patients taking other heart medicines called ACE inhibitors, U.S. experts recommended on Thursday, despite finding problems with a trial of the medicine.
|
|
